Finance

Lists
RMD:ASX
Resmed CDI
32,00 A$
+1,01%
(+0,32) 1D
30 սեպ, 15:54:51 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
31,74 A$
High
32,10 A$
Low
31,74 A$
Mkt. cap
32,14 մլրդ
Avg. vol.
1,26 մլն
Volume
280,97 հզր
52-wk high
43,29 A$
52-wk low
25,50 A$
Shares outstanding
144,25 մլն
No. of employees
11 հզր
Open
31,74 A$
High
32,10 A$
Low
31,74 A$
Mkt. cap
32,14 մլրդ
Avg. vol.
1,26 մլն
Volume
280,97 հզր
52-wk high
43,29 A$
52-wk low
25,50 A$
Shares outstanding
144,25 մլն
No. of employees
11 հզր
News stories
From web sources and news partners
The Motley Fool Australia
The Motley Fool Australia
·
1 օր առաջ
Is the ResMed share price a cheap buy?
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11,4 հզր
Foundedհնս 1989
HeadquartersՍան Դիեգո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteresmed.com
Last report
06 օգս, 2026 թ.
Fiscal period
Q4 2026
EPS / Est. (USD)
0,30 $ / 2,89 $
-89,80%miss
Revenue / Est. (USD)
1,46 մլրդ / 1,46 մլրդ
+0,21%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,34 մլրդ
1,42 մլրդ
1,43 մլրդ
1,46 մլրդ
Cost of goods sold
506,94 մլն
536,28 մլն
532,58 մլն
594,13 մլն
Cost of revenue
506,94 մլն
536,28 մլն
532,58 մլն
594,13 մլն
Research and development expenses
87,32 մլն
90,97 մլն
94,27 մլն
105,72 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 մլն
275,70 մլն
279,80 մլն
293,36 մլն
Operating expense
366,29 մլն
386,24 մլն
393,16 մլն
417,88 մլն
Total operating expenses
873,24 մլն
922,51 մլն
925,74 մլն
1,01 մլրդ
Operating income
462,35 մլն
500,30 մլն
505,67 մլն
451,64 մլն
Other non operating income
-3,84 մլն
42,00 հզր
181,00 հզր
4,40 մլն
EBT including unusual items
446,79 մլն
496,15 մլն
502,31 մլն
474,16 մլն
EBT excluding unusual items
468,79 մլն
504,48 մլն
518,30 մլն
476,09 մլն
Income tax expense
98,26 մլն
103,56 մլն
103,58 մլն
90,73 մլն
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 մլն
392,59 մլն
398,73 մլն
383,43 մլն
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 մլն
4,46 մլն
3,80 մլն
31,76 մլն
Interest expense
-
-
-
-
Net interest expenses
4,69 մլն
4,46 մլն
3,80 մլն
31,76 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 մլն
543,79 մլն
558,22 մլն
490,13 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps